Selank Peptide 10mg – Protide Health USA

Selank Peptide Overview & Technical Specifications

Selank peptide is a synthetic tuftsin-derived heptapeptide composed of seven amino acids:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

The abbreviated sequence is:

TKPRPGP

and the complete terminal representation is:

H-TKPRPGP-OH

The supplied PubChem record identifies Selank as:

• PubChem CID: 11765600
• CAS Number: 129954-34-3
• Molecular Formula: C33H57N11O9
• Molecular Weight: approximately 751.88 g/mol

Protide Health supplies Selank peptide as 10mg of 99% purity lyophilized research material in a 3mL vial for biochemical, neuropeptide, molecular, cellular, analytical, and qualified preclinical research.

Technical Specifications

• Product Name: Selank
• Synonyms: TP-7, Selanc
• Quantity: 10mg
• Form: Lyophilized powder
• Vial Size: 3mL
• Purity: 99%
• Testing: HPLC-MS verified; third-party tested
• Peptide Type: Synthetic tuftsin-derived heptapeptide
• Peptide Length: 7 amino acids
• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
• Abbreviated Sequence: TKPRPGP
• Terminal Representation: H-TKPRPGP-OH
• CAS Number: 129954-34-3
• PubChem CID: 11765600
• Molecular Formula: C33H57N11O9
• Molecular Weight: approximately 751.88 g/mol
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in water
• Storage: Store sealed at ≤6°C and protected from heat, light, and moisture
• Research Use: Biochemical, neuropeptide, cellular, molecular, analytical, and qualified preclinical research only

Selank Peptide Structure & Tuftsin-Derived Research

The Selank peptide sequence was developed from the endogenous tetrapeptide tuftsin:

Thr-Lys-Pro-Arg

Selank extends that sequence with:

Pro-Gly-Pro

to form:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

or TKPRPGP.

This relationship to tuftsin has contributed to scientific interest in Selank across neurochemical and immunoregulatory research.

Published experimental work has investigated pathways involving:

• GABAergic neurotransmission
• Gene-expression regulation
• Cytokine and chemokine signaling
• Enkephalin metabolism
• BDNF-associated pathways
• Monoamine metabolism
• Stress-response systems
• Behavioral models

These research areas do not establish therapeutic outcomes for the Protide Health material.

GABAergic Signaling Research

One prominent area of Selank peptide research concerns the GABAergic system.

A rat gene-expression study examined 84 genes associated with neurotransmission after Selank exposure.

Researchers reported changes in multiple genes involved in:

• GABA receptor signaling
• Ion channels
• Neurotransmitter transport
• Dopamine receptors
• Serotonin receptors

The expression pattern showed similarities to changes observed after GABA exposure, leading investigators to propose that one possible mechanism of Selank research activity may involve modulation of GABAergic neurotransmission.

This remains a mechanistic experimental interpretation rather than evidence that the Protide Health product produces a defined clinical effect.

Selank & Gene-Expression Research

Selank has also been examined through molecular gene-expression studies.

Published experiments have reported changes involving genes related to:

• Neurotransmission
• Chemokines
• Cytokines
• Immune signaling
• Neuroreceptor pathways

Such findings suggest that Selank may interact with multiple regulatory systems rather than functioning through one isolated receptor.

However, gene-expression changes are highly dependent on:

• Experimental model
• Tissue
• Exposure conditions
• Timing
• Measured gene panel

They should not be interpreted as direct therapeutic outcomes.

Enkephalin Metabolism Research

Another experimental area for Selank peptide involves endogenous enkephalin metabolism.

A published study reported that Selank inhibited enzymatic hydrolysis of enkephalins in an experimental system.

Researchers proposed that altered enkephalin degradation could contribute to some observed neurobehavioral responses.

Enkephalins are endogenous opioid peptides involved in multiple neurological and physiological pathways.

This mechanism should be interpreted cautiously because biochemical enzyme inhibition does not establish a clinical effect from a laboratory research product.

BDNF & Neurotrophin Research

Brain-derived neurotrophic factor, or BDNF, has also been studied in connection with Selank.

A rat study involving long-term ethanol exposure evaluated:

• Hippocampal BDNF
• Frontal-cortex BDNF
• Object-recognition behavior
• Memory-related experimental endpoints

Changes in BDNF-associated measurements were reported following experimental Selank exposure.

These findings support the use of Selank peptide in neurotrophin-related research models but do not establish cognitive enhancement or neurological treatment effects in humans.

Monoamine Research

Preclinical work has examined Selank in relation to monoamine neurotransmitters and their metabolites.

Mouse research has evaluated:

• Norepinephrine
• Dopamine
• Serotonin
• DOPAC
• HVA
• 5-HIAA

Responses varied depending on mouse strain and brain region.

This variability is scientifically important because it demonstrates that Selank-associated neurochemical responses can depend strongly on biological context.

The literature therefore does not support describing Selank as producing one universal neurotransmitter effect.

Selank Benefits: What the Evidence Supports

The keyword selank benefits frequently appears in consumer-oriented searches.

Published research has examined Selank in connection with:

• Anxiety-related experimental models
• GABA-associated signaling
• Enkephalin metabolism
• BDNF-related pathways
• Memory-related models
• Neurotransmitter gene expression
• Cytokine and chemokine signaling

Some human studies have also been published, primarily from Russian research groups investigating anxiety-related disorders.

However, this evidence should not be converted into claims that the Protide Health Selank peptide treats anxiety, improves cognition, enhances mood, or provides other medical benefits.

The Protide Health product is a laboratory research material rather than a regulated therapeutic product.

Human Selank Research Context

A limited human literature exists for standard Selank.

For example, a 2014 comparative study involving 60 patients evaluated Selank and phenazepam in anxiety-related disorders and reported differences in efficacy and tolerability measures.

A separate study involving generalized anxiety disorder and neurasthenia examined Selank alongside medazepam and also evaluated enkephalin-related biological endpoints.

These studies provide clinical-research history for the molecule.

However:

• They do not establish FDA approval.
• They do not establish suitability of the Protide Health material for humans.
• They do not justify transferring the protocols used in those studies to a research vial.
• Much of the human evidence is relatively limited and geographically concentrated.

Selank Side Effects & Safety Research

The search phrase selank side effects concerns human tolerability.

Some published clinical studies reported tolerability observations with pharmaceutical or experimental Selank preparations.

For example, comparative anxiety-disorder studies have examined Selank alongside benzodiazepine-class comparators.

Those findings do not establish a general safety profile for the Protide Health product.

Important distinctions include:

• Study formulations may differ.
• Routes of exposure may differ.
• Quality specifications may differ.
• Controlled research populations do not represent unrestricted use.
• Short study durations cannot establish universal long-term safety.

For these reasons, no human safety claim is made for this research material.

Selank and Semax Research Comparison

The keyword selank and semax refers to two structurally distinct research peptides.

Selank

• Sequence: TKPRPGP
• Tuftsin-derived
• Seven amino acids
• Research includes GABAergic, enkephalin, gene-expression, and BDNF-related pathways

Semax

Semax is derived from an ACTH-related peptide sequence and belongs to a different structural class.

Research involving Semax has focused on different neurotrophic, melanocortin-related, and gene-expression pathways.

The two compounds should not be treated as chemically interchangeable.

Selank vs Semax

The query selank vs semax is best addressed through structural and mechanistic differences rather than declaring one peptide superior.

Selank and Semax differ in:

• Primary sequence
• Parent peptide
• Molecular weight
• Experimental targets
• Published literature
• Biological models studied

The appropriate research compound depends on the experimental hypothesis.

There is no scientific basis for universally labeling one as “better.”

Semax vs Selank

The reversed query semax vs selank involves the same comparison.

Both molecules are investigated in neuropeptide research, but research findings for one should not automatically be assigned to the other.

Researchers comparing Semax and Selank peptide should use peptide-specific analytical standards and experimental controls.

Selank Reddit Search Intent

The search phrase selank reddit reflects interest in user discussions and anecdotal reports.

Anecdotal online experiences are not equivalent to controlled scientific evidence.

Reports on forums can vary in:

• Product identity
• Purity
• Source
• Preparation
• Claimed route of administration
• Concurrent substances
• Individual expectations

For scientific product content, PubMed-indexed studies and verified chemical records provide a more appropriate evidence base than anonymous anecdotal reports.

Standard Selank vs N-Acetyl Selank Analogues

Standard Selank peptide should be distinguished from terminally modified Selank analogues.

Standard Selank

• Sequence: H-TKPRPGP-OH
• Formula: C33H57N11O9
• Molecular Weight: ~751.88 g/mol
• PubChem CID: 11765600
• CAS: 129954-34-3

Modified Selank Analogues

Modified forms may incorporate:

• N-terminal acetylation
• C-terminal amidation
• Alternative terminal chemistry

Those modifications change the molecular identity and can alter physicochemical behavior.

Research findings should therefore be matched to the actual Selank form used in an experiment.

Research Format & Storage

Protide Health supplies Selank peptide as:

• Quantity: 10mg
• Form: Lyophilized powder
• Vial Size: 3mL
• Appearance: White to off-white
• Purity: 99%
• Testing: HPLC-MS verified; third-party tested
• Solubility: Soluble in water

According to the supplied specifications:

• Store at ≤6°C
• Keep sealed
• Protect from heat
• Protect from direct light
• Protect from moisture

These are laboratory storage characteristics rather than human preparation or administration instructions.

Research Limitations

Several limitations should be considered when interpreting Selank research:

• A large portion of the mechanistic evidence is preclinical.
• Many studies originate from a relatively concentrated group of investigators.
• Rodent behavioral findings cannot establish equivalent human effects.
• GABA-associated gene-expression changes do not establish clinical anxiolytic efficacy.
• BDNF changes do not establish cognitive enhancement.
• Monoamine responses vary by strain and brain region.
• Enkephalinase inhibition does not establish a therapeutic effect.
• Limited human studies cannot establish general long-term safety.
• Online anecdotes do not substitute for controlled evidence.
• Research findings from modified Selank analogues should not automatically be attributed to standard Selank.
• The Protide Health product is not an FDA-approved pharmaceutical product.

Accordingly, Selank peptide is supplied strictly for qualified laboratory research.

Literature & Citation Index

The Inhibitory Effect of Selank on Enkephalin-Degrading Enzymes as a Possible Mechanism of Its Anxiolytic Activity

Year: 2001
PMID: 11550013
DOI: 10.1023/A:1017979514274
Research Context: Parent Selank, enkephalin degradation, plasma enkephalinase activity, and proposed neurochemical mechanisms.

Effects of Heptapeptide Selank on the Content of Monoamines and Their Metabolites in the Brain of BALB/C and C57Bl/6 Mice

Year: 2008
PMID: 19093364
Research Context: Norepinephrine, dopamine, serotonin, monoamine metabolites, brain-region differences, and mouse-strain-dependent responses.

Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank

Year: 2008
PMID: 18454096
Research Context: Human comparative research involving anxiety disorders, psychometric assessments, and enkephalin-associated measurements.

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission

Year: 2016
PMID: 26924987
Research Context: GABAergic pathways, neurotransmission-associated genes, receptor expression, ion channels, and rat frontal-cortex research.

Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating BDNF Content

Year: 2019
PMID: 31625062
DOI: 10.1007/s10517-019-04588-9
Research Context: BDNF, hippocampus, prefrontal cortex, object recognition, and chronic ethanol-exposure rat models.

Related Protide Health Research Products

Researchers comparing Selank peptide with other experimental peptide systems may review Cagrilintide for a structurally and mechanistically distinct peptide research model.

The Cartalax 20mg research peptide provides another short-peptide system for comparative laboratory investigation.

Researchers may also examine CJC-1295 No DAC 10mg for a GHRH-receptor-focused peptide research model with a completely different sequence and mechanism.

These products should not be considered interchangeable with Selank.

Frequently Asked Questions

What is Selank peptide?

Selank peptide is a synthetic seven-amino-acid peptide derived from the tuftsin sequence. Its amino-acid sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro.

What is the Selank sequence?

The sequence is:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

or:

TKPRPGP

What is the molecular formula of Selank?

The verified formula is C33H57N11O9, with molecular weight approximately 751.88 g/mol.

What is the CAS number for Selank?

The verified CAS number is 129954-34-3.

What is the PubChem CID?

The verified PubChem identifier is CID 11765600.

What does Selank peptide research investigate?

Research has examined GABAergic neurotransmission, gene expression, BDNF-related pathways, enkephalin metabolism, cytokine and chemokine signaling, monoamine metabolism, and behavioral models.

What are the Selank benefits?

Some studies report experimental neurochemical, behavioral, and gene-expression effects, but those results do not establish therapeutic or cognitive benefits for the Protide Health research product.

What are Selank side effects?

Limited human research includes tolerability observations, but those studies do not establish a universal human safety profile for this laboratory material.

What is the difference between Selank vs Semax?

Selank is a tuftsin-derived heptapeptide, whereas Semax is derived from an ACTH-related sequence. They differ structurally and mechanistically.

Is Semax vs Selank a question of which is better?

No. The compounds have different structures and research pathways, so neither can scientifically be labeled universally superior.

Is information from Selank Reddit discussions reliable scientific evidence?

No. Selank reddit discussions may provide anecdotal experiences, but they are not substitutes for controlled laboratory or clinical research.

What purity does Protide Health specify?

Protide Health specifies 99% purity, with HPLC-MS verification and third-party testing.

What form is Selank supplied in?

Selank peptide is supplied as 10mg of white to off-white lyophilized research material in a 3mL vial.

Is Selank intended for human use?

No. This product is supplied solely for biochemical, neuropeptide, cellular, molecular, analytical, in-vitro, and qualified preclinical research.

Laboratory Terms & Compliance

Laboratory Research Use Only

This Selank peptide product is supplied exclusively for laboratory research, analytical testing, in-vitro studies, molecular research, cellular studies, and qualified preclinical experimentation.

It is not intended for human or veterinary consumption, medical use, diagnostic use, psychiatric treatment, cognitive enhancement, therapeutic use, nasal administration, injection, or clinical administration.

No human dosage, administration frequency, injection protocol, nasal preparation, treatment cycle, or human-use preparation instructions are provided.

The purchaser is responsible for appropriate laboratory handling, storage, and use under applicable institutional, federal, state, and local requirements.

For research use only.